Us Fda Grants Breakthrough Device Designation For Curvebeam Ai S Ossview Bone Fragility Software

Us Fda Grants Breakthrough Device Designation For Curvebeam Ai S Ossview Bone Fragility Software

Curvebeam Ai Ltd Announced Its Medical Diagnostic Software, Ossview, Has Received Us Food And Drug Administration (Fda) Breakthrough Device Designation. Ossview Calculates A Structural Fragility Score (Sfs), Which Determines Bone Microstructural Deterioration, A Highly Accurate Indicator For Bone Fragility And Fracture Risk.Ossview Is Investigational Only And Is Not Available For Sale In The United States.The Goal Of The Fda Breakthrough Devices Programme Is To Provide Patients And Health Care Providers With Timely Access To Medical Devices That Provide For More Effective Treatment Or Diagnosis Of Irreversibly Debilitating Diseases By Speeding Up Their Development, Assessment, And Review, While Preserving The Statutory Standards For Premarket Approval.Benefits Associated With Acceptance Into The Breakthrough Devices Programme Include Prioritized Review Of Fda 510(K) Applications.The Current Standard Of Care To Determine Fragility Fracture Risk In Patients Is Bone Mineral Density (Bmd) Measurements Obtained Via Dual Energy X-Ray (Dxa). In Some Cases, The Fracture Risk Assessment Tool (Frax) Software Is Used To Further Identify Fracture Risk. These Approaches Miss Patients Who Are Non-Osteoporotic But Still At Risk For Fragility Fracture

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!